iNOS Associates With Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation
Zhen Ding(Shandong University), Elizabeth A. Grimm(The University of Texas MD Anderson Cancer Center), Sühendan Ekmekçioğlu(The University of Texas MD Anderson Cancer Center), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Yong Qin(The University of Texas MD Anderson Cancer Center), Dai Ogata(Unknown), Sun‐Hee Kim(Ewha Womans University), Michael T. Tetzlaff(Hospital of the University of Pennsylvania), Jason Roszik(The University of Texas MD Anderson Cancer Center)
Cited by 39
Related Papers
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
|Journal of Clinical Oncology|2018|925
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
|The Lancet Oncology|2012|906